Watchman FLX: Early "Real World" Experience in Search for the Perfect Closure
- PMID: 33189646
- DOI: 10.1016/j.jcin.2020.07.043
Watchman FLX: Early "Real World" Experience in Search for the Perfect Closure
Keywords: Watchman FLX; device related thrombus; left atrial appendage closure; peridevice leak.
Conflict of interest statement
Author Disclosures Dr. Rogers is a consultant to Abbott, Boston Scientific, and Gore. Dr. Singh is a consultant to Abbott and Boston Scientific. Dr. Saw has received unrestricted research grant support from the Canadian Institutes of Health Research, the Heart & Stroke Foundation of Canada, the National Institutes of Health, AstraZeneca, Abbott Vascular, St. Jude Medical, Boston Scientific, and Servier; has received salary support from the Michael Smith Foundation for Health Research; has received speaking honoraria from AstraZeneca, Abbott Vascular, Boston Scientific, and Bayer; has received consultancy and advisory board honoraria from AstraZeneca, Boston Scientific, Abbott Vascular, Gore, and Abiomed; and has received proctorship honoraria from Abbott Vascular and Boston Scientific.
Comment on
-
Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device.JACC Cardiovasc Interv. 2020 Dec 14;13(23):2732-2741. doi: 10.1016/j.jcin.2020.06.056. Epub 2020 Nov 11. JACC Cardiovasc Interv. 2020. PMID: 33189641
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
